McKesson posts Q3 lift of 3%

SAN FRANCISCO – McKesson earlier this week reported that revenues for the third quarter ended Dec. 31, 2015 were $47.9 billion, up 3%. 

 

“Our outlook for fiscal 2016 and fiscal 2017 remains the same as what we provided on Jan. 11, 2016,” stated John Hammergren, chairman and CEO. “Our third-quarter results were in line with our expectations and I am pleased with the excellent progress we have made in expanding our global pharmaceutical sourcing scale, delivering operating margin improvements in the Technology Solutions segment, and successfully executing on the Celesio acquisition synergies. As we enter the final months of Fiscal 2016 and look to the future, I remain confident in our industry and the role we play in making the business of healthcare more efficient."

 

Distribution Solutions revenues were $47.2 billion for the quarter, up 3% on a reported basis and up 6% on a constant currency basis.

 

North America pharmaceutical distribution and services revenues were $39.6 billion for the quarter, up 6% on a reported basis and 7% on a constant currency basis, primarily driven by market growth. Earlier this month, McKesson announced it will source pharmaceuticals for the Target pharmacies acquired by CVS Health.